Detalhe da pesquisa
1.
Different outcomes among patients with intermediate-risk metastastic renal cell carcinoma treated with first-line tyrosine-kinase inhibitors.
Clin Transl Oncol
; 26(2): 532-537, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37505371